Galapagos plans to discontinue its small molecule discovery programs and seek potential partners to take over these assets, including the TYK2 inhibitor, GLPG3667, currently in Phase 2 for systemic ...
Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.
Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...
Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed Joerg Moeller, MD, PhD ...
Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing ...
Canyon Labs, a leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, has ...
Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has entered into a ...
Expands Phillips Medisize’s inhalation drug delivery capabilities.
ProBioGen has expanded both protein and virus manufacturing at its Berlin headquarters—including the commissioning of an ...
Adheres to requirements, including 21 CFR Part 820 and Good Manufacturing Practices.
Platinum Press Inc. (PPI), a provider of printed packaging solutions, has completed a $15 million expansion and ...
WuXi Biologics plans to sell its vaccine facility in Dundalk, Ireland to Merck & Co. for approximately $500 million. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback